Top 4 Stocks In The Drugs-Generic Industry With The Highest Operating Margin
Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at Akorn (NASDAQ: AKRX) is 27.84%. Akorn's PEG ratio is 2.02.
The trailing-twelve-month operating margin at Salix Pharmaceuticals (NASDAQ: SLXP) is 26.47%. Salix Pharmaceuticals' ROE for the same period is 17.90%.
The trailing-twelve-month operating margin at Mylan (NASDAQ: MYL) is 19.42%. Mylan's revenue for the same period is $6.82 billion.
The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co (NASDAQ: HITK) is 15.88%. Hi-Tech Pharmacal had $108.28 million in total cash for the latest quarter.
Posted-In: Drugs-Generic Industry Operating MarginTrading Ideas
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
